HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $5 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Gossamer Bio (NASDAQ:GOSS) and maintained a $5 price target.
August 10, 2023 | 10:30 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated a 'Buy' rating on Gossamer Bio, maintaining a $5 price target.
The reiteration of a 'Buy' rating by HC Wainwright & Co. indicates their continued confidence in Gossamer Bio. The maintained price target of $5 suggests they believe the stock is undervalued at current levels. This could potentially lead to increased investor interest and upward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100